These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28895102)

  • 1. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.
    Panjwani S; Moore MD; Gray KD; Finnerty BM; Beninato T; Brunaud L; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2017 Nov; 24(12):3617-3623. PubMed ID: 28895102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical analysis of lymph node examination in patients undergoing curative-intent resection for adrenocortical carcinoma.
    Deschner BW; Stiles ZE; DeLozier OM; Drake JA; Tsao M; Glazer ES; Deneve JL; Yakoub D; Dickson PV
    J Surg Oncol; 2020 Nov; 122(6):1152-1162. PubMed ID: 32705677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Lymph Nodes in Adrenocortical Carcinoma: What Does It Mean?
    Sada A; Glasgow AE; Lyden ML; Thompson GB; Dy BM; McKenzie TJ; Habermann EB
    World J Surg; 2021 Jan; 45(1):188-194. PubMed ID: 33034710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.
    Nilubol N; Patel D; Kebebew E
    World J Surg; 2016 Mar; 40(3):697-705. PubMed ID: 26510563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
    Giuliante F; Ardito F; Guglielmi A; Aldrighetti L; Ferrero A; Calise F; Giulini SM; Jovine E; Breccia C; De Rose AM; Pinna AD; Nuzzo G
    JAMA Surg; 2016 Oct; 151(10):916-922. PubMed ID: 27556741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Prognostic Value of Lymph Node Dissection in Treating Adrenocortical Carcinoma: A National Experience.
    Alanee S; Dynda D; Holland B
    Anticancer Res; 2015 Oct; 35(10):5575-9. PubMed ID: 26408728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
    Gerry JM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Wang TS; Glenn JA; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Hatzaras I; Shenoy R; Pawlik TM; Norton JA; Poultsides GA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):708-713. PubMed ID: 27590329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.
    Datta J; Lewis RS; Mamtani R; Stripp D; Kelz RR; Drebin JA; Fraker DL; Karakousis GC; Roses RE
    Cancer; 2014 Sep; 120(18):2855-65. PubMed ID: 24854027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
    Ball MW; Schwen ZR; Ko JS; Meyer A; Netto GJ; Burnett AL; Bivalacqua TJ
    Investig Clin Urol; 2017 Jan; 58(1):20-26. PubMed ID: 28097264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma.
    Dong F; Xu L; Peng X; Xu T; Shen Y; Gao F; Wang X; Zhang X; Chen S; Zhang M; Zhong S; Ding Q
    Jpn J Clin Oncol; 2018 Oct; 48(10):942-949. PubMed ID: 30137442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing therapeutic lymphadenectomy: Location of regional metastatic lymph nodes in adrenocortical carcinoma.
    Sada A; Glasgow AE; Lyden ML; Dy BM; Foster TR; Habermann EB; Bancos I; McKenzie TJ
    Am J Surg; 2022 Jun; 223(6):1042-1045. PubMed ID: 34696848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
    Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
    Reibetanz J; Rinn B; Kunz AS; Flemming S; Ronchi CL; Kroiss M; Deutschbein T; Pulzer A; Hahner S; Kocot A; Germer CT; Fassnacht M; Jurowich C
    Ann Surg Oncol; 2019 Feb; 26(2):531-538. PubMed ID: 30443830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
    Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
    Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.